Zhang Li, Yi Boyu, Xia Zhigui, Huang Fang
National Institute of Parasitic Diseases, Chinese Center for Disease Control and Prevention, Chinese Center for Tropical Diseases Research, WHO Collaborating Center for Tropical Diseases, National Centre for International Research on Tropical Diseases, NHC Key Laboratory of Parasite and Vector Biology (National Institute of Parasitic Diseases, Chinese Center for Disease Control and Prevention), Shanghai, China.
China CDC Wkly. 2022 Jul 15;4(28):609-613. doi: 10.46234/ccdcw2022.133.
WHAT IS ALREADY KNOWN ABOUT THIS TOPIC?: () was the most widely distributed and major human malaria parasite in China, considered the last parasite to be eliminated.
WHAT IS ADDED BY THIS REPORT?: The last domestic case was reported in 2016, while hundreds of imported cases were reported annually from 2013-2020, predominantly from Southeast Asia.
WHAT ARE THE IMPLICATIONS FOR PUBLIC HEALTH PRACTICE?: In the post-elimination phase, adaptive and practical strategies focusing on imported cases should be updated and adopted to prevent malaria resurgence.
关于该主题已知的信息有哪些？：（）曾是中国分布最广且主要的人体疟原虫，被认为是最后一个要被消除的疟原虫。
本报告新增了哪些内容？：国内最后一例病例于2016年报告，而在2013 - 2020年期间，每年报告数百例输入性病例，主要来自东南亚。
对公共卫生实践有哪些启示？：在消除疟疾后的阶段，应更新并采用针对输入性病例的适应性和实用性策略，以防止疟疾卷土重来。
